Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto

The requirements of a specialist breast centre

(2020) Laura Biganzoli et al.   BREAST

Cost-effectiveness of long-term clinical management of BRCA pathogenic variant carriers

(2020) Lara Petelin et al.   GENETICS IN MEDICINE

How public health services pay for radiotherapy in Europe: an ESTRO–HERO analysis of reimbursement

(2020) Yolande Lievens et al.   LANCET ONCOLOGY

International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic

(2020) C.E. Coles et al.   CLINICAL ONCOLOGY

ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)

(2020) S. Paluch-Shimon et al.   ANNALS OF ONCOLOGY

Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer

(2020) Julia Simoes Correa-Galendi et al.   Applied Health Economics and Health Policy

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)†

(2020) F. Cardoso et al.   ANNALS OF ONCOLOGY

Breast cancer surgery after the COVID-19 pandemic

(2020) Fiona Tsang-Wright et al.   Future Oncology

Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial

(2020) Birgitte V. Offersen et al.   JOURNAL OF CLINICAL ONCOLOGY

The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review

(2020) Gustavo Nader Marta et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands

(2019) Carmen van Dooijeweert et al.   BREAST CANCER RESEARCH AND TREATMENT

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2019) F Cardoso et al.   ANNALS OF ONCOLOGY

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019

(2019) Marc Thill et al.   Breast Care

Breast Cancer: Reimbursement Policies and Adoption of New Therapeutic Agents by National Health Systems

(2019) Dario Trapani et al.   Breast Care

National costs and resource requirements of external beam radiotherapy: A time-driven activity-based costing model from the ESTRO-HERO project

(2019) Noemie Defourny et al.   RADIOTHERAPY AND ONCOLOGY

Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019

(2019) H J Burstein et al.   ANNALS OF ONCOLOGY

Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe

(2018) E.J. Blok et al.   CANCER TREATMENT REVIEWS

Value-Based Pricing and Patient Access for Specialty Drugs

(2018) James C. Robinson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The ICER Value Framework: Integrating Cost Effectiveness and Affordability in the Assessment of Health Care Value

(2018) Steven D. Pearson   VALUE IN HEALTH

Expenditures on Oncology Drugs and Cancer Mortality‐to‐Incidence Ratio in Central and Eastern Europe

(2018) Eduard Vrdoljak et al.   ONCOLOGIST

Variation in the Use of Boost Irradiation in Breast-Conserving Therapy in the Netherlands: The Effect of a National Guideline and Cofounding Factors

(2018) K. Schreuder et al.   CLINICAL ONCOLOGY

European Breast Cancer Council manifesto 2018: Genetic risk prediction testing in breast cancer

(2018) Emiel Rutgers et al.   EUROPEAN JOURNAL OF CANCER

Integration of oncology and palliative care: a Lancet Oncology Commission

(2018) Stein Kaasa et al.   LANCET ONCOLOGY

Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update

(2017) Betty R. Ferrell et al.   JOURNAL OF CLINICAL ONCOLOGY

ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe

(2016) N. Cherny et al.   ANNALS OF ONCOLOGY

Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†

(2016) S. Paluch-Shimon et al.   ANNALS OF ONCOLOGY

Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey

(2016) Francesco Sardanelli et al.   EUROPEAN RADIOLOGY

Cost and Burden of Female Breast Cancer in Portugal

(2016) R Sousa et al.   VALUE IN HEALTH

Expanding global access to radiotherapy: the European Society for Radiotherapy and Oncology perspective

(2015) Philip Poortmans et al.   LANCET ONCOLOGY

Expanding global access to radiotherapy

(2015) Rifat Atun et al.   LANCET ONCOLOGY

Global cancer surgery: delivering safe, affordable, and timely cancer surgery

(2015) Richard Sullivan et al.   LANCET ONCOLOGY

Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study

(2014) Ann E. McCullough et al.   BREAST CANCER RESEARCH AND TREATMENT

Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey

(2014) Cai Grau et al.   RADIOTHERAPY AND ONCOLOGY

Changing Physician Incentives for Affordable, Quality Cancer Care: Results of an Episode Payment Model

(2014) Lee N. Newcomer et al.   Journal of Oncology Practice

Delivering affordable cancer care in high-income countries

(2011) Richard Sullivan et al.   LANCET ONCOLOGY